Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Marion Eisele is active.

Publication


Featured researches published by Marion Eisele.


Acta Psychiatrica Scandinavica | 2010

Risk factors for incident mild cognitive impairment – results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe)

Tobias Luck; Sg Riedel-Heller; Melanie Luppa; Birgitt Wiese; Anja Wollny; Michael Wagner; Horst Bickel; Siegfried Weyerer; Michael Pentzek; Franziska Haller; Edelgard Moesch; Jochen Werle; Marion Eisele; W. Maier; H. van den Bussche; Hanna Kaduszkiewicz

Luck T, Riedel‐Heller SG, Luppa M, Wiese B, Wollny A, Wagner M, Bickel H, Weyerer S, Pentzek M, Haller F, Moesch E, Werle J, Eisele M, Maier W, van den Bussche H, Kaduszkiewicz H for the AgeCoDe Study Group. Risk factors for incident mild cognitive impairment – results from the German Study on Ageing, Cognition and Dementia in Primary Care Patients (AgeCoDe).


American Journal of Geriatric Psychiatry | 2012

Prediction of Incident Dementia: Impact of Impairment in Instrumental Activities of Daily Living and Mild Cognitive Impairment—Results From the German Study on Ageing, Cognition, and Dementia in Primary Care Patients

Tobias Luck; Melanie Luppa; Birgit Wiese; Wolfgang Maier; Hendrik van den Bussche; Marion Eisele; Frank Jessen; Dagmar Weeg; Siegfried Weyerer; Michael Pentzek; Hanna Leicht; Mirjam Koehler; Franziska Tebarth; Julia Olbrich; Sandra Eifflaender-Gorfer; Angela Fuchs; Hans-Helmut Koenig; Steffi G. Riedel-Heller

OBJECTIVES There is an increasing call for a stronger consideration of impairment in instrumental activities of daily living (IADL) in the diagnostic criteria of Mild Cognitive Impairment (MCI) to improve the prediction of dementia. Thus, the aim of the study was to determine the predictive capability of MCI and IADL impairment for incident dementia. DESIGN Longitudinal cohort study with four assessments at 1.5-year intervals over a period of 4.5 years. SETTING : Primary care medical record registry sample. PARTICIPANTS As part of the German Study on Ageing, Cognition, and Dementia in Primary Care Patients, a sample of 3,327 patients from general practitioners, aged 75 years and older, was assessed. MEASUREMENTS The predictive capability of MCI and IADL impairment for incident dementia was analysed using receiver operating characteristics, Kaplan-Meier survival analyses, and Cox proportional hazards models. RESULTS MCI and IADL impairment were found to be significantly associated with higher conversion to, shorter time to, and better predictive power for future dementia. Regarding IADL, a significant impact was particularly found for impairment in responsibility for ones own medication, shopping, and housekeeping, and in the ability to use public transport. CONCLUSIONS Combining MCI with IADL impairment significantly improves the prediction of future dementia. Even though information on a set of risk factors is required to achieve a predictive accuracy for dementia in subjects with MCI being clinically useful, IADL impairment should be a very important element of such a risk factor set.


Annals of Family Medicine | 2014

Prognosis of Mild Cognitive Impairment in General Practice: Results of the German AgeCoDe Study

Hanna Kaduszkiewicz; Marion Eisele; Birgitt Wiese; Jana Prokein; Melanie Luppa; Tobias Luck; Frank Jessen; Horst Bickel; Edelgard Mösch; Michael Pentzek; Angela Fuchs; Sandra Eifflaender-Gorfer; Siegfried Weyerer; Hans-Helmut König; Christian Brettschneider; Hendrik van den Bussche; Wolfgang Maier; Martin Scherer; Steffi G. Riedel-Heller

PURPOSE The concept of mild cognitive impairment (MCI) has recently been introduced into the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5) as mild neurocognitive disorder, making it a formal diagnosis. We investigated the prognostic value of such a diagnosis and analyzed the determinants of the future course of MCI in the AgeCoDe study (German Study on Ageing, Cognition, and Dementia in Primary Care Patients). METHODS We recruited 357 patients with MCI aged 75 years or older from primary care practices and conducted follow-up with interviews for 3 years. Depending on the course of impairment over time, the patients were retrospectively split into 4 groups representing remittent, fluctuating, stable, and progressive courses of MCI. We performed ordinal logistic regression analysis and classification and regression tree (CART) analysis. RESULTS Overall, 41.5% of the patients had remission of symptoms with normal cognitive function 1.5 and 3 years later, 21.3% showed a fluctuating course, 14.8% had stable symptoms, and 22.4% had progression to dementia. Patients were at higher risk for advancing from one course to the next along this spectrum if they had symptoms of depression, impairment in more than 1 cognitive domain, or more severe cognitive impairment, or were older. The result on a test of the ability to learn and reproduce new material 10 minutes later was the best indicator at baseline for differentiating between remittent and progressive MCI. Symptoms of depression modified the prognosis. CONCLUSIONS In primary care, about one-quarter of patients with MCI have progression to dementia within the next 3 years. Assessments of memory function and depressive symptoms are helpful in predicting a progressive vs a remittent course. When transferring the concept of MCI into clinical diagnostic algorithms (eg, DSM-5), however, we should not forget that three-quarters of patients with MCI stayed cognitively stable or even improved within 3 years. They should not be alarmed unnecessarily by receiving such a diagnosis.


Acta Psychiatrica Scandinavica | 2012

Assessing cognitive changes in the elderly: Reliable Change Indices for the Mini‐Mental State Examination

Janine Stein; Melanie Luppa; W. Maier; Michael Wagner; Steffen Wolfsgruber; Martin Scherer; Mirjam Köhler; Marion Eisele; Siegfried Weyerer; Jochen Werle; Horst Bickel; Edelgard Mösch; Birgitt Wiese; Jana Prokein; Michael Pentzek; Angela Fuchs; Hanna Leicht; Hans-Helmut König; Sg Riedel-Heller

Stein J, Luppa M, Maier W, Wagner M, Wolfsgruber S, Scherer M, Köhler M, Eisele M, Weyerer S, Werle J, Bickel H, Mösch E, Wiese B, Prokein J, Pentzek M, Fuchs A, Leicht H, König H‐H, Riedel‐Heller SG for the AgeCoDe Study Group. Assessing cognitive changes in the elderly: Reliable Change Indices for the Mini‐Mental State Examination.


BMC Psychiatry | 2011

Impact of geriatric comorbidity and polypharmacy on cholinesterase inhibitors prescribing in dementia

Falk Hoffmann; Hendrik van den Bussche; Birgitt Wiese; Gerhard Schön; Daniela Koller; Marion Eisele; Gerd Glaeske; Martin Scherer; Hanna Kaduszkiewicz

BackgroundAlthough most guidelines recommend the use of cholinesterase inhibitors (ChEIs) for mild to moderate Alzheimers Disease, only a small proportion of affected patients receive these drugs. We aimed to study if geriatric comorbidity and polypharmacy influence the prescription of ChEIs in patients with dementia in Germany.MethodsWe used claims data of 1,848 incident patients with dementia aged 65 years and older. Inclusion criteria were first outpatient diagnoses for dementia in at least three of four consecutive quarters (incidence year). Our dependent variable was the prescription of at least one ChEI in the incidence year. Main independent variables were polypharmacy (defined as the number of prescribed medications categorized into quartiles) and measures of geriatric comorbidity (levels of care dependency and 14 symptom complexes characterizing geriatric patients). Data were analyzed by multivariate logistic regression.ResultsOn average, patients were 78.7 years old (47.6% female) and received 9.7 different medications (interquartile range: 6-13). 44.4% were assigned to one of three care levels and virtually all patients (92.0%) had at least one symptom complex characterizing geriatric patients. 13.0% received at least one ChEI within the incidence year. Patients not assigned to the highest care level were more likely to receive a prescription (e.g., no level of care dependency vs. level 3: adjusted Odds Ratio [OR]: 5.35; 95% CI: 1.61-17.81). The chance decreased with increasing numbers of symptoms characterizing geriatric patients (e.g., 0 vs. 5+ geriatric complexes: OR: 4.23; 95% CI: 2.06-8.69). The overall number of prescribed medications had no influence on ChEI prescription and a significant effect of age could only be found in the univariate analysis. Living in a rural compared to an urban environment and contacts to neurologists or psychiatrists were associated with a significant increase in the likelihood of receiving ChEIs in the multivariate analysis.ConclusionsIt seems that not age as such but the overall clinical condition of a patient including care dependency and geriatric comorbidities influences the process of decision making on prescription of ChEIs.


International Journal of Health Geographics | 2010

Ambulatory health services utilization in patients with dementia - Is there an urban-rural difference?

Daniela Koller; Marion Eisele; Hanna Kaduszkiewicz; Gerhard Schön; Susanne Steinmann; Birgitt Wiese; Gerd Glaeske; Hendrik van den Bussche

BackgroundDue to demographic changes and an un-equal distribution of physicians, regional analyses of service utilization of elderly patients are crucial, especially for diseases with an impact like dementia. This paper focuses on dementia patients. The aim of the study is to identify differences in service utilization of incident dementia patients in urban and rural areas.MethodsBasis for the analysis were all insured persons of a German Health Insurance fund (the GEK) aged 65 years and older living in rural and urban areas. We focussed on physician contacts in the outpatient sector during the first year after an incidence diagnosis of dementia. Special attention was given to contacts with primary care physicians and neurologists/psychiatrists. The dementia cohort was analyzed together with a non-dementia control group drawn according to age, gender and amount of physician contacts. Uni- and bivariate as well as multivariate analysis were performed to estimate the influences on service utilization.ResultsResults show that the provision of primary care seems to be equally given in urban and rural areas. For specialists contacts however, rural patients are less likely to consult neurologists or psychiatrists. This trend can already be seen before the incident diagnosis of dementia. All consultations rise in the quarter of the incident dementia diagnosis compared to the control group. The results were also tested in a linear and a logistic regression, showing a higher chance for persons living in urban areas to visit a specialist and an overall higher rate in service utilization for dementia patients.ConclusionsBecause of a probable increase in the number of dementia patients, service provision has to be accessible even in rural areas. Due to this and the fact that demographic change is happening at different paces in different regions, regional variations have to be considered to ensure the future service provision.


Dementia and Geriatric Cognitive Disorders | 2010

Utilization Patterns of Ambulatory Medical Care before and after the Diagnosis of Dementia in Germany ― Results of a Case-Control Study

Marion Eisele; Hendrik van den Bussche; Daniela Koller; Birgitt Wiese; Hanna Kaduszkiewicz; Wolfgang Maier; Gerd Glaeske; Susanne Steinmann; Karl Wegscheider; Gerhard Schön

Aims: To analyze how the diagnosis of dementia changes the utilization of the ambulatory medical care services in the German statutory health insurance. Methods: In this case-control study, claims data of 1,848 insurants aged ≧65 years with incident dementia and 7,392 matched controls were compared regarding their utilization of ambulatory medical care services. Results: We found an increase in the utilization of ambulatory medical care services by demented patients of 50% in the year before and of 40% in the year after the incidence, predominantly in primary care and neurology/psychiatry settings. A negative interaction effect of age and gender (p ≤ 0.000) was found regarding the number of visited physicians. Conclusion: Service utilization by demented patients increases already within the year before the first diagnosis and stays on a relatively high level within the year after. Especially (female) patients aged 80 years and older at dementia onset ought to be observed to prevent a possible undersupply.


International Clinical Psychopharmacology | 2011

Antidementia drug prescription sources and patterns after the diagnosis of dementia in Germany: results of a claims data-based 1-year follow-up.

Hendrik van den Bussche; Hanna Kaduszkiewicz; Daniela Koller; Marion Eisele; Susanne Steinmann; Gerd Glaeske; Birgitt Wiese

We examined the patterns of prescription for antidementia drugs by German physicians with special reference to source of prescription, appropriateness of drugs and dosages and continuity of prescription patterns. The study is based on claims data of all 1848 incident cases in persons aged 65 years and older from a nationwide operating statutory health insurance company in the years 2004–2006. Inclusion criteria were one International Statistical Classification of Diseases and Related Health Problems 10th Revision code for dementia in at least three of four consecutive quarters and four quarters without such a code beforehand. Defined daily doses were used to quantify the prescription size. Data analysis used univariate and multivariate techniques. The majority of incident dementia cases in general and Alzheimers disease cases in particular did not receive medication in conformity with the guidelines during the year after incidence. Inappropriate prescription was related to not visiting a specialist, living in urban areas, age and comorbidity. Further research is needed both on reasons for nonprescription among professionals and for discontinuation by the patients. In addition, the problems of practicability and implementation of guidelines deserve more attention.


International Journal of Geriatric Psychiatry | 2009

At-risk alcohol drinking in primary care patients aged 75 years and older

Siegfried Weyerer; Martina Schäufele; Sandra Eifflaender-Gorfer; Leonore Köhler; Wolfgang Maier; Franziska Haller; Gabriela Cvetanovska-Pllashiniku; Michael Pentzek; Angela Fuchs; Hendrik van den Bussche; Thomas Zimmermann; Marion Eisele; Horst Bickel; Edelgard Mösch; Birgitt Wiese; Matthias C. Angermeyer; Steffi G. Riedel-Heller

Little is known about the prevalence and risk factors of alcohol problems among older people (especially those aged 75 years and more). The aims of this study were to report alcohol consumption patterns and to determine their association with socio‐demographic variables and health characteristics.


BMC Geriatrics | 2012

Influence of social support on cognitive change and mortality in old age: results from the prospective multicentre cohort study AgeCoDe

Marion Eisele; Thomas Zimmermann; Mirjam Köhler; Birgitt Wiese; Kathrin Heser; Franziska Tebarth; Dagmar Weeg; Julia Olbrich; Michael Pentzek; Angela Fuchs; Siegfried Weyerer; Jochen Werle; Hanna Leicht; Hans-Helmut König; Melanie Luppa; Steffi G. Riedel-Heller; Wolfgang Maier; Martin Scherer

BackgroundSocial support has been suggested to positively influence cognition and mortality in old age. However, this suggestion has been questioned due to inconsistent operationalisations of social support among studies and the small number of longitudinal studies available. This study aims to investigate the influence of perceived social support, understood as the emotional component of social support, on cognition and mortality in old age as part of a prospective longitudinal multicentre study in Germany.MethodsA national subsample of 2,367 primary care patients was assessed twice over an observation period of 18 months regarding the influence of social support on cognitive function and mortality. Perceived social support was assessed using the 14-item version of the FSozU, which is a standardised and validated questionnaire of social support. Cognition was tested by the neuropsychological test battery of the Structured Interview for the Diagnosis of Dementia (SIDAM). The influence of perceived support on cognitive change was analysed by multivariate ANCOVA; mortality was analysed by multivariate logistic and cox regression.ResultsSample cognitive change (N = 1,869): Mean age was 82.4 years (SD 3.3) at the beginning of the observation period, 65.9% were female, mean cognition was 49 (SD 4.4) in the SIDAM. Over the observation period cognitive function declined in 47.2% by a mean of 3.4 points. Sample mortality (N = 2,367): Mean age was 82.5 years (SD 3.4), 65.7% were female and 185 patients died during the observation period. Perceived social support showed no longitudinal association with cognitive change (F = 2.235; p = 0.135) and mortality (p = 0.332; CI 0.829-1.743).ConclusionsPerceived social support did not influence cognition and mortality over an 18 months observation period. However, previous studies using different operationalisations of social support and longer observation periods indicate that such an influence may exist. This influence is rather small and the result of complex interaction mechanisms between different components of social support; the emotional component seems to have no or only a limited effect. Further research is needed to describe the complex interactions between components of social support. Longer observation periods are necessary and standardised operationalisations of social support should be applied.

Collaboration


Dive into the Marion Eisele's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Michael Pentzek

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar

Angela Fuchs

University of Düsseldorf

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge